On Wednesday, OpenAI countersued Elon Musk, accusing him of utilizing harassment ways to sluggish the corporate’s progress and disrupt its plans for development, together with a contentious bid for management.
What Occurred: Within the lawsuit, OpenAI alleges that Musk’s ways embody press assaults, authorized harassment, and an unsolicited bid for the corporate’s property.
The submitting states, “Musk has tried each software accessible to hurt OpenAI,” and asks the court docket to cease him from taking additional “illegal” actions, reported Reuters.
The dispute facilities on OpenAI’s transition to a for-profit mannequin, which is essential for its present $40 billion fundraising spherical. OpenAI goals to finish this transition by the tip of the yr, however Musk has tried to dam it.
See Additionally: OpenAI’s Sam Altman Seems To Increase Funds From Abu Dhabi’s MGX Amid Elevated Competitors: Report
In a submit on X, OpenAI added that Musk’s actions have been “bad-faith ways to decelerate OpenAI and seize management of the main AI improvements for his private profit.”
Subscribe to the Benzinga Tech Traits publication to get all the newest tech developments delivered to your inbox.
Why It Issues: OpenAI was co-founded in 2015 by 11 individuals, together with Musk and present CEO Sam Altman. Nonetheless, Musk parted methods with the corporate in 2018, previous to its rise as a significant tech participant following the discharge of ChatGPT.
In 2023, Musk based his separate synthetic intelligence firm, xAI, and has since opposed OpenAI’s shift towards a for-profit construction.
Earlier this yr, OpenAI’s board rejected a $97 billion acquisition proposal from Musk, which was seen as an try and decelerate a competitor.
In the meantime, OpenAI has additionally finalized a historic $40 billion funding spherical, elevating its valuation to $300 billion. This funding is backed by main gamers like Microsoft Corp. MSFT and SoftBank Group SFTBF SFTBY.
Picture through Shutterstock
Take a look at extra of Benzinga’s Client Tech protection by following this hyperlink.
Learn Subsequent:
Disclaimer: This content material was partially produced with the assistance of Benzinga Neuro and was reviewed and revealed by Benzinga editors.
Market Information and Knowledge dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
